E-LIB Suche - Ergebnisse für: Fink, K.

1

Effectiveness of first generation disease-modifying therapy..:

Tedeholm, H ; Piehl, F ; Lycke, J...
Multiple Sclerosis and Related Disorders, 2211-0348, 2022, 68,. , 2022

Link: http://urn.kb.se/resolve..

2

Effectiveness of first generation disease-modifying therapy..:

Tedeholm, H ; Piehl, F ; Lycke, J...
Multiple Sclerosis and Related Disorders, 2211-0348, 2022, 68,. , 2022

Link: http://urn.kb.se/resolve..

3

Effectiveness of first generation disease-modifying therapy..:

Tedeholm, H ; Piehl, F ; Lycke, J...
Multiple Sclerosis and Related Disorders, 2211-0348, 2022, 68,. , 2022

Link: http://urn.kb.se/resolve..

4

Effectiveness of first generation disease-modifying therapy..:

Tedeholm, H ; Piehl, F ; Lycke, J...
https://acuresearchbank.acu.edu.au/item/8y97x/effectiveness-of-first-generation-disease-modifying-therapy-to-prevent-conversion-to-secondary-progressive-multiple-sclerosis. , 2022

Link: https://acuresearchbank...

5

Vergleich konventionell, eingefärbter - gegen farblose Wisc..:

Fink, K ; Baier, C ; Krettek, C.
http://dx.doi.org/10.3205/21dkou521. , 2021

Link: https://doi.org/10.3205/..

6

Terminal Ligand and Packing Effects on Slow Relaxation in a..:

Pfleger, R. F ; Schlittenhardt, S ; Merkel, M. P...
info:eu-repo/semantics/altIdentifier/wos/000707136900001. , 2021

Link: https://publikationen.bi..

7

Inhibiting glycolysis rescues memory impairment in an intel..:

D'Adamo P ; Horvat A ; Gurgone A...
info:eu-repo/semantics/altIdentifier/pmid/33309713. , 2021

Link: http://hdl.handle.net/23..

8

Kann die Ketoacidose bei pädiatrischen Patienten mit Manife..:

Mönkemöller, K ; Kamrath, C ; Hammersen, J...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s00112-020-01108-2. , 2021

Link: https://push-zb.helmholt..

9

Mapping Neutralizing and Immunodominant Sites on the SARS-C..:

Piccoli L ; Park Y. -J ; Tortorici M. A...
info:eu-repo/semantics/altIdentifier/pmid/32991844. , 2020

Link: http://hdl.handle.net/24..

10

Translational outcomes in a full gene deletion of ubiquitin..:

Berg, E. L ; Pride, M. C ; Petkova, S. P...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026078/. , 2020

Link: http://www.ncbi.nlm.nih...

11

Cancer Risk for Fingolimod, Natalizumab, and Rituximab in M..:

Alping, P ; Askling, J ; Burman, J...
Annals of Neurology, 0364-5134, 2020, 87:5, s. 688-699. , 2020

Link: http://urn.kb.se/resolve..

12

Ultrapotent human antibodies protect against SARS-CoV-2 cha..:

Tortorici M. A ; Beltramello M ; Lempp F. A...
info:eu-repo/semantics/altIdentifier/pmid/32972994. , 2020

Link: http://hdl.handle.net/24..

13

A Human Antibody Neutralizes Different Flaviviruses by Usin..:

Zhang, S ; Loy, T ; Ng, T.-S...
Zhang, S., Loy, T., Ng, T.-S., Lim, X.-N., Chew, S.-Y.V., Tan, T.Y., Xu, M., Kostyuchenko, V.A., Tukijan, F., Shi, J., Fink, K., Lok, S.-M. (2020). A Human Antibody Neutralizes Different Flaviviruses by Using Different Mechanisms. Cell Reports 31 (4) : 107584. ScholarBank@NUS Repository. https://doi.org/10.1016/j.celrep.2020.107584. , 2020

Link: https://scholarbank.nus...

14

Primary lateral sclerosis : consensus diagnostic criteria:

Turner M. R ; Barohn R. J ; Corcia P...
info:eu-repo/semantics/altIdentifier/pmid/32029539. , 2020

Link: http://hdl.handle.net/24..

15

Single molecule, near full-length genome sequencing of deng..:

Adikari, T.N ; Riaz, N ; Sigera, C...
Adikari, T.N., Riaz, N., Sigera, C., Leung, P., Valencia, B.M., Barton, K., Smith, M.A., Bull, R.A., Li, H., Luciani, F., Weeratunga, P., Thein, T.-L., Lim, V.W.X., Leo, Y.-S., Rajapakse, S., Fink, K., Lloyd, A.R., Fernando, D., Rodrigo, C. (2020). Single molecule, near full-length genome sequencing of dengue virus. Scientific Reports 10 (1) : 18196. ScholarBank@NUS Repository. https://doi.org/10.1038/s41598-020-75374-1. , 2020

Link: https://scholarbank.nus...